Abbott’s Humira, Approved in Japan
First it was Roche’s Actimra, now it is Abbott’s Humira that’s been approved in Japan.
The Japanese Ministry of Health, Labour and Welfare has approved Humira for the treatment of rheumatoid arthritis (RA) in patients with inadequate response to conventional therapy.
“The approval of HUMIRA in Japan is a significant milestone for Abbott,” said Glenn Warner, vice president, Pharmaceuticals, Japan, Abbott. “This approval is both good news for Japanese patients and a significant step forward for Abbott in Japan.”
I would like the patients to understand their condition better in order to help them discern what is best for their life with arthritis in conjunction to what their doctors are telling them! .. 
